Skip to main content
. Author manuscript; available in PMC: 2019 Feb 16.
Published in final edited form as: Circ Res. 2018 Feb 16;122(4):624–638. doi: 10.1161/CIRCRESAHA.117.311586

Fig. 1.

Fig. 1

Pathophysiological mechanisms of diabetic cardiomyopathy. Hyperglycemia, insulin resistance, and hyperinsulinemia induce cardiac insulin resistance and metabolic disorders that increase mitochondria dysfunction, oxidative stress, AGEs, impairment of mitochondria Ca2+ handling, inflammation, activation of RAAS, autonomic neuropathy, endoplasmic reticulum stress, cardiomyocyte death, as well as microvascular dysfunction. These pathophysiological abnormalities promote cardiac stiffness, hypertrophy, and fibrosis, resulting in cardiac diastolic dysfunction, systolic dysfunction, and heart failure. Abbreviations: AGEs, advanced glycation end-products; RAAS, renin-angiotensin-aldosterone system.